Enumera Molecular
About:
Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.
Website: https://www.enumeramolecular.com/
Top Investors: Arboretum Ventures
Description:
Enumera Molecular is a life science tools company headquartered in Ann Arbor, MI, developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests. It helps in transforming the field of clinical molecular testing into a simpler, more actionable tool for physicians to benefit patient care.
Total Funding Amount:
$12.5M
Headquarters Location:
Ann Arbor, Michigan, United States
Founded Date:
2022-01-01
Founders:
Matthew Cooper
Number of Employees:
11-50
Last Funding Date:
2022-05-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai